
|Videos|December 5, 2021
Dr. Garraway summarizes SUO session on early detection and treatment of prostate cancer
Author(s)Urology Times staff
“It’s really important to look at the pathology we’ve learned before considering these patients for active surveillance treatment,” says Isla Garraway, MD, PhD.
Advertisement
In this video, Isla Garraway, MD, PhD, discusses key points of the session on early detection and treatment of prostate cancer that was presented at the 2021 Society of Urologic Oncology Annual Meeting. Garraway is an associate professor and director of research in the department of urology, and a member of the Jonsson Comprehensive Cancer Center and Broad Center for Regenerative Medicine at the UCLA School of Medicine in Los Angeles, California.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The ArteraAI Prostate Test: What It Is and How It Works
2
HHS requests testosterone therapy label updates, citing new safety data
3
FDA approves tebipenem pivoxil for complicated urinary tract infections
4
Retrospective study suggests differences in OAB therapy persistence among older adults
5











